tiprankstipranks
Trending News
More News >
BioMark Diagnostics (TSE:BUX)
:BUX
Advertisement

BioMark Diagnostics (BUX) Revenue

Compare
3 Followers

BioMark Diagnostics Revenue

BioMark Diagnostics had a revenue of 38.99K in the quarter ending Dec 31, 2024, with 1.11%. This bring the company's revenue in the last twelve months to 154.22K, Increased -0.52%. In the fiscal year ending Dec 31, 2024, BioMark Diagnostics had annual revenue of 154.22K with -5.52% growth.
Revenue (ttm)
154.22K
Revenue Growth
-5.52%
P/S Ratio
252.14
Revenue/Employee
Employees
Market Cap
C$38.88M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
154.22K-9.00K-5.52%
Dec 31, 2023
163.22K9.73K+6.34%
Dec 31, 2022
153.49K109.56K+249.38%
Dec 31, 2021
43.93K+∞%
Dec 31, 2020
0.00-263.28K-100.00%
Dec 31, 2019
263.28K+∞%
Dec 31, 2018
0.00
Dec 31, 2017
0.00
Dec 31, 2016
0.00
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis